文献速递乳腺MR

超快速动态增强MRI初始强化分析对乳腺病变的诊断效能

Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
PubMed 文献 · Eur Radiol · 2018-08-07

本研究在200例受试者共215个乳腺病变(147个恶性、68个良性)中,评估超快速DCE-MRI初始强化指标TTE和MS对良恶性鉴别的诊断价值及其对BI-RADS分类的补充作用。结果显示TTE和MS在肿块与非肿块强化中均有显著差异,TTE+MS联合BI-RADS对非肿块强化的AUC显著高于单独BI-RADS(0.923 vs 0.865,p=0.036),特异度提高40.9%(p=0.005)而敏感度无显著下降(p=0.083)。

要点

  • 超快速DCE-MRI的TTE和MS在肿块与非肿块强化中均能显著区分良恶性病变。
  • 对非肿块强化,TTE+MS联合BI-RADS的AUC显著高于单独BI-RADS(0.923 vs 0.865,p=0.036)。
  • 非肿块强化中联合方案特异度提高40.9%(p=0.005),敏感度无显著下降(p=0.083)。

核心结论

  • 超快速DCE-MRI初始强化分析尤其有助于提高乳腺MRI对非肿块强化的诊断效能。

研究设计与样本

  • 经机构审查委员会批准的前瞻性研究,200例受试者共215个病变(147个恶性、68个良性),均行超快速DCE-MRI初始强化分析及常规MRI,以常规MRI进行BI-RADS分类。

诊断标准与关键数值

  • 从超快速DCE-MRI提取初始强化指标TTE和MS;肿块中TTE恶性与良性差异p<.001、MS差异p=.006;非肿块强化中TTE和MS差异均p<.001;肿块中TTE+MS联合BI-RADS的AUC为0.864,单独BI-RADS为0.823(p=.065);非肿块强化中联合AUC为0.923,单独BI-RADS为0.865(p=.036),特异度提高40.9%(p=.005),敏感度无显著下降(p=.083)。

临床应用与阅片要点

  • 在乳腺MRI阅片中对非肿块强化病变可结合超快速DCE-MRI的TTE和MS进行初始强化分析,以辅助BI-RADS分类。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the diagnostic value and contribution to BI-RADS categorisation of initial enhancement on ultra-fast DCE-MRI for differentiating malignant and benign breast lesions.

METHODS: The institutional review board approved this study, and written informed consent was obtained from each participant. Both ultra-fast DCE-MRI for initial enhancement analysis and conventional MRI were performed on 200 subjects with a total of 215 lesions (147 malignant and 68 benign). BI-RADS categorisation of enhancing lesions was performed using the conventional MRI. Two initial enhancement measures, time to enhancement (TTE) and maximum slope (MS), were derived from the ultra-fast DCE-MRI. Diagnostic performance and the additional diagnostic value of adding TTE and MS to BI-RADS were evaluated.

RESULTS: Both TTE and MS showed significant differences between malignant and benign breast lesions in masses (TTE, p <.001; MS, p = .006) and non-mass enhancement (NME) (TTE, p <.001; MS, p <.001). For masses, the AUC of TTE+MS combined with BI-RADS (0.864) was better than BI-RADS alone (0.823, p = .065). For NME, the AUC of TTE+MS combined with BI-RADS (0.923) was significantly larger than BI-RADS alone (0.865, p = .036), and diagnostic specificity improved by 40.9% (p = .005), without a significant decrease in the sensitivity (p = .083).

CONCLUSION: Initial enhancement analysis using ultra-fast DCE-MRI is especially useful for increasing the diagnostic performance of NME in breast MRI.

KEY POINTS: • Ultra-fast dynamic MRI effectively differentiates benign from malignant breast lesions. • Ultra-fast dynamic MRI contributes to BI-RADS categorisation in non-mass enhancement. • Management of non-mass breast lesions becomes more appropriate.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Goto M, Sakai K, Yokota H, et al. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions. Eur Radiol. 2018. PMID: 30088064. doi:10.1007/s00330-018-5643-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。